An FDA effort to speed approval of new medicines allowed drugs onto the market without proper safety analysis, according to two drug-safety experts.
Agency let risky drugs hit market, experts say
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.